Product
TALIMOGENE LAHERPAREPVEC
1 clinical trial
3 indications
Indication
MelanomaIndication
Merkel Cell CarcinomaIndication
Solid TumorsClinical trial
A Phase II Randomized Trial of Intralesional Talimogene Laherparepvec (TALIMOGENE LAHERPAREPVEC) With or Without Radiotherapy for Cutaneous Melanoma, Merkel Cell Carcinoma, or Other Solid TumorsStatus: Completed, Estimated PCD: 2024-02-22